Company / EPS (Basic)
CUMBERLAND PHARMACEUTICALS INC EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.46
FY2025
5-year range
-$0.46 / -$0.23
FY2021-FY2025
Trend
-4.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has declined for 4 consecutive years, from $-0.23 in FY2021 to $-0.46 in FY2025.
Based on SEC 10-K filings.
-0.46 in FY2025.
Declined from $-0.38 to $-0.46 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- CUMBERLAND PHARMACEUTICALS INC's eps (basic) has declined for 4 consecutive years.
- In FY2025, eps (basic) decreased 4.5% year-over-year.
- Peak eps (basic) was recorded in FY2016.
- Lowest eps (basic) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.46 | -4.5% |
| FY2024 | -$0.44 | -15.8% |
| FY2023 | -$0.38 | -58.3% |
| FY2022 | -$0.24 | -4.3% |
| FY2021 | -$0.23 | +48.9% |
| FY2020 | -$0.45 | +10.0% |
| FY2019 | -$0.50 | -733.3% |
| FY2018 | -$0.06 | -250.0% |
| FY2017 | $0.04 | -71.4% |
| FY2016 | $0.14 | +227.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026